Aarkstore.com announce The Latest report -Acorda Therapeutics, Inc. – Product Pipeline Review – 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Acorda Therapeutics, Inc. – Product Pipeline Review – 2012
http://www.aarkstore.com/reports/Acorda-Therapeutics-Inc-Product-
Pipeline-Review-2012-217860.html
Summary
Global Market Direct’s pharmaceuticals report, “Acorda Therapeutics, Inc. - Product
Pipeline Review - 2012” provides data on the Acorda Therapeutics, Inc.’s research
and development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Acorda Therapeutics, Inc.’s corporate website, SEC filings,
investor presentations and featured press releases, both from Acorda Therapeutics,
Inc. and industry-specific third party sources, put together by Global Markets
Direct’s team.
Scope
- Acorda Therapeutics, Inc. - Brief Acorda Therapeutics, Inc. overview including
business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Acorda Therapeutics, Inc. human therapeutic
division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.

2. Table of contents:
List of Tables 5
List of Figures 5
Acorda Therapeutics, Inc. Snapshot 6
Acorda Therapeutics, Inc. Overview 6
Key Information 6
Key Facts 6
Acorda Therapeutics, Inc. – Research and Development Overview 7
Key Therapeutic Areas 7
Acorda Therapeutics, Inc. – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Acorda Therapeutics, Inc. – Pipeline Products Glance 11
Acorda Therapeutics, Inc. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Acorda Therapeutics, Inc. – Early Stage Pipeline Products 13
Pre-Clinical Products/Combination Treatment Modalities 13
Acorda Therapeutics, Inc. – Drug Profiles 14
AC105 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Chondroitinase Program 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
GGF2 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
rHIgM22 19
Product Description 19
Mechanism of Action 19
R&D Progress 19

3. List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review&PubId=&pagenum=1
Acacia Pharma Ltd. – Product Pipeline Review – 2012
Acceleron Pharma, Inc. – Product Pipeline Review – 2012
Access Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Achaogen Inc. – Product Pipeline Review – 2012
Acorda Therapeutics, Inc. – Product Pipeline Review – 2012
Glycotope GmbH – Product Pipeline Review – 2012
Aquinox Pharmaceuticals Inc. – Product Pipeline Review – 2012
Avaxia Biologics, Inc. – Product Pipeline Review – 2012
Bharat Biotech International Limited – Product Pipeline Review – 2012
Bio3 Research S.r.l – Product Pipeline Review – 2012
Cardax Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Cellceutix Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Curacyte AG – Product Pipeline Review – 2012

4. Fresenius Biotech GmbH – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
You can also request for sample page of above mention reports on
sample@aarkstore.com
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com